NDC 71335-2972 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-2972

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA209389
Marketed since
June 19, 2025
Listing expires
December 31, 2027
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (8)

Package NDCDescriptionSince
71335-2972-120 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-1)Oct 29, 2025
71335-2972-260 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-2)Oct 29, 2025
71335-2972-330 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-3)Oct 29, 2025
71335-2972-410 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-4)Oct 29, 2025
71335-2972-515 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-5)Oct 29, 2025
71335-2972-66 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-6)Oct 29, 2025
71335-2972-73 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-7)Oct 29, 2025
71335-2972-85 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2972-8)Oct 29, 2025

Other Ondansetron products